Report cover image

AI In Pathology Market Size, Share, Trends, Industry Analysis Report By Offering, By Neural Network, By Function, By Use Case, By End User, By Region – Market Forecast, 2025–2034

Published Oct 01, 2025
SKU # PLRS20566105

Description

The AI in Pathology market size is expected to reach USD 113.02 Billion by 2034, according to a new study by Polaris Market Research. The report “AI In Pathology Market Size, Share, Trends, Industry Analysis Report By Offering, By Neural Network, By Function, By Use Case, By End User, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in Pathology market is witnessing strong growth driven by the rising prevalence of cancer and chronic diseases, the growing adoption of digital pathology, and increasing demand for accurate and efficient diagnostic solutions.

Advancements in deep learning, computer vision, and image analysis are accelerating diagnostic workflows and improving precision in disease detection. Leading players are focusing on developing scalable and interoperable AI-driven pathology platforms that enhance diagnostic accuracy, support personalized medicine, and meet global healthcare innovation and digital transformation goals.

AI In Pathology Market Report Highlights

Based on offering, the end-to-end solutions segment dominated the market in 2024, driven by their ability to provide comprehensive support across the entire pathology workflow from image acquisition to diagnostics and reporting.

In terms of neural network type, the convolutional neural networks (CNN) segment held the largest share in 2024, owing to their proven accuracy in image recognition, segmentation, and classification tasks within digital pathology.

By function, the image analysis segment led the market in 2024, fueled by growing adoption of AI tools to automate routine pathology tasks, minimize diagnostic errors, and improve laboratory throughput.

Based on use case, the disease diagnosis and prognosis segment accounted for the largest share in 2024, supported by increasing demand for early and precise detection of cancer, infectious diseases, and chronic disorders.

In terms of end user, the hospitals and reference laboratories segment dominated the market in 2024, driven by rapid implementation of AI-assisted digital pathology systems for both routine and complex diagnostic workflows.

North America accounted for a significant share in 2024, supported by strong integration of digital pathology and AI-based diagnostic tools across healthcare and research institutions.

The Asia Pacific market grew rapidly in 2024, fueled by expanding healthcare digitalization, increasing investments in AI infrastructure, and growing adoption of AI-driven pathology solutions across emerging economies.

A few key global players include Aiforia Technologies Plc, Akoya Biosciences, Inc., Deep Bio Inc., Hologic, Inc., Ibex Medical Analytics Ltd., Indica Labs Inc., Koninklijke Philips N.V., Mindpeak GmbH, OptraScan, Inc., Paige AI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, and Visiopharm A/S.

Polaris Market Research has segmented the market report on the basis of offering, neural network, function, use case, end user, and region:

By Offering Outlook (Revenue, USD Billion, 2020–2034)

End-to-End Solutions

Niche Point Solutions

Technology

Hardware

Microscopes

Scanners

Storage Systems

By Neural Network Outlook (Revenue, USD Billion, 2020–2034)

Convolutional Neural Networks (CNNS)

Generative Adversarial Networks (GANS)

Recurrent Neural Networks (RNNS)

Other Neural Networks

By Function Outlook (Revenue, USD Billion, 2020–2034)

Image Analysis

Diagnostics

Workflow Management

Data Management

Predictive Analytics

CDSS

Automated Report Generation

Quality Assurance Tools

By Use Case Outlook (Revenue, USD Billion, 2020–2034)

Drug Discovery

Disease Diagnosis & Prognosis

Clinical Workflow

Training & Education

By End User Outlook (Revenue, USD Billion, 2020–2034)

Pharmaceutical & Biopharmaceutical Companies

Hospitals & Reference Laboratories

Academic & Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. AI In Pathology Market Insights
4.1. AI In Pathology Market – Market Snapshot
4.2. AI In Pathology Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Cancer and Chronic Diseases
4.2.1.2. Increasing R&D Investments in Biomarker Discovery
4.2.2. Restraints and Challenges
4.2.2.1. High Implementation Costs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. AI In Pathology Market Trends
4.6. Value Chain Analysis
5. AI In Pathology Market, by Offering
5.1. Key Findings
5.2. Introduction
5.2.1. AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
5.3. End-To-End Solutions
5.3.1. AI In Pathology Market, by End-To-End Solutions, by Region, 2020-2034 (USD Billion)
5.4. Niche Point Solutions
5.4.1. AI In Pathology Market, by Niche Point Solutions, 2020-2034 (USD Billion)
5.5. Technology
5.5.1. AI In Pathology Market, by Technology, by Region, 2020-2034 (USD Billion)
5.6. Hardware
5.6.1. AI In Pathology Market, by Hardware, by Region, 2020-2034 (USD Billion)
5.7. Microscopes
5.7.1. AI In Pathology Market, by Microscopes, by Region, 2020-2034 (USD Billion)
5.8. Scanners
5.8.1. AI In Pathology Market, by Scanners, by Region, 2020-2034 (USD Billion)
5.9. Storage Systems
5.9.1. AI In Pathology Market, by Storage Systems, by Region, 2020-2034 (USD Billion)
6. AI In Pathology Market, by Neural Network
6.1. Key Findings
6.2. Introduction
6.2.1. AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
6.3. Convolutional Neural Networks (CNNS)
6.3.1. AI In Pathology Market, by Convolutional Neural Networks (CNNS), by Region, 2020-2034 (USD Billion)
6.4. Generative Adversarial Networks (GANS)
6.4.1. AI In Pathology Market, by Generative Adversarial Networks (GANS), by Region, 2020-2034 (USD Billion)
6.5. Recurrent Neural Networks (RNNS)
6.5.1. AI In Pathology Market, by Recurrent Neural Networks (RNNS), by Region, 2020-2034 (USD Billion)
6.6. Other Neural Networks
6.6.1. AI In Pathology Market, by Other Neural Networks, by Region, 2020-2034 (USD Billion)
7. AI In Pathology Market, by Function
7.1. Key Findings
7.2. Introduction
7.2.1. AI In Pathology Market, by Function, 2020-2034 (USD Billion)
7.3. Image Analysis
7.3.1. AI In Pathology Market, by Image Analysis, by Region, 2020-2034 (USD Billion)
7.4. Diagnostics
7.4.1. AI In Pathology Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
7.5. Workflow Management
7.5.1. AI In Pathology Market, by Workflow Management, by Region, 2020-2034 (USD Billion)
7.6. Data Management
7.6.1. AI In Pathology Market, by Data Management, by Region, 2020-2034 (USD Billion)
7.7. Predictive Analytics
7.7.1. AI In Pathology Market, by Predictive Analytics, by Region, 2020-2034 (USD Billion)
7.8. CDSS
7.8.1. AI In Pathology Market, by CDSS, by Region, 2020-2034 (USD Billion)
7.9. Automated Report Generation
7.9.1. AI In Pathology Market, by Automated Report Generation, by Region, 2020-2034 (USD Billion)
7.10. Quality Assurance Tools
7.10.1. AI In Pathology Market, by Quality Assurance Tools, by Region, 2020-2034 (USD Billion)
8. AI In Pathology Market, by Use Case
8.1. Key Findings
8.2. Introduction
8.2.1. AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
8.3. Drug Discovery
8.3.1. AI In Pathology Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
8.4. Disease Diagnosis & Prognosis
8.4.1. AI In Pathology Market, by Disease Diagnosis & Prognosis, by Region, 2020-2034 (USD Billion)
8.5. Clinical Workflow
8.5.1. AI In Pathology Market, by Clinical Workflow, by Region, 2020-2034 (USD Billion)
8.6. Training & Education
8.6.1. AI In Pathology Market, by Training & Education, by Region, 2020-2034 (USD Billion)
9. AI In Pathology Market, by End User
9.1. Key Findings
9.2. Introduction
9.2.1. AI In Pathology Market, by End User, 2020-2034 (USD Billion)
9.3. Pharmaceutical & Biopharmaceutical Companies
9.3.1. AI In Pathology Market, by Pharmaceutical & Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
9.4. Hospitals & Reference Laboratories
9.4.1. AI In Pathology Market, by Hospitals & Reference Laboratories, by Region, 2020-2034 (USD Billion)
9.5. Academic & Research Institutes
9.5.1. AI In Pathology Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
10. AI In Pathology Market, by Geography
10.1. Key Findings
10.2. Introduction
10.2.1. AI In Pathology Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. AI In Pathology Market – North America
10.3.1. North America: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.3.2. North America: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.3.3. North America: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.3.4. North America: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.3.5. North America: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.3.6. AI In Pathology Market – U.S.
10.3.6.1. U.S.: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.3.6.2. U.S.: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.3.6.3. U.S.: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.3.6.4. U.S.: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.3.6.5. U.S.: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.3.7. AI In Pathology Market – Canada
10.3.7.1. Canada: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.3.7.2. Canada: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.3.7.3. Canada: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.3.7.4. Canada: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.3.7.5. Canada: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4. AI In Pathology Market – Europe
10.4.1. Europe: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.2. Europe: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.3. Europe: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.4. Europe: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.5. Europe: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.6. AI In Pathology Market – UK
10.4.6.1. UK: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.6.2. UK: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.6.3. UK: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.6.4. UK: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.6.5. UK: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.7. AI In Pathology Market – France
10.4.7.1. France: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.7.2. France: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.7.3. France: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.7.4. France: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.7.5. France: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.8. AI In Pathology Market – Germany
10.4.8.1. Germany: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.8.2. Germany: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.8.3. Germany: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.8.4. Germany: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.8.5. Germany: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.9. AI In Pathology Market – Italy
10.4.9.1. Italy: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.9.2. Italy: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.9.3. Italy: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.9.4. Italy: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.9.5. Italy: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.10. AI In Pathology Market – Spain
10.4.10.1. Spain: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.10.2. Spain: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.10.3. Spain: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.10.4. Spain: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.10.5. Spain: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.11. AI In Pathology Market – Netherlands
10.4.11.1. Netherlands: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.11.2. Netherlands: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.11.3. Netherlands: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.11.4. Netherlands: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.11.5. Netherlands: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.12. AI In Pathology Market – Russia
10.4.12.1. Russia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.12.2. Russia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.12.3. Russia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.12.4. Russia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.12.5. Russia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.4.13. AI In Pathology Market – Rest of Europe
10.4.13.1. Rest of Europe: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.4.13.2. Rest of Europe: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.4.13.3. Rest of Europe: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.4.13.4. Rest of Europe: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.4.13.5. Rest of Europe: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5. AI In Pathology Market – Asia Pacific
10.5.1. Asia Pacific: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.2. Asia Pacific: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.3. Asia Pacific: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.4. Asia Pacific: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.5. Asia Pacific: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.6. AI In Pathology Market – China
10.5.6.1. China: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.6.2. China: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.6.3. China: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.6.4. China: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.6.5. China: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.7. AI In Pathology Market – India
10.5.7.1. India: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.7.2. India: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.7.3. India: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.7.4. India: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.7.5. India: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.8. AI In Pathology Market – Malaysia
10.5.8.1. Malaysia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.8.2. Malaysia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.8.3. Malaysia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.8.4. Malaysia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.8.5. Malaysia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.9. AI In Pathology Market – Japan
10.5.9.1. Japan: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.9.2. Japan: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.9.3. Japan: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.9.4. Japan: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.9.5. Japan: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.10. AI In Pathology Market – Indonesia
10.5.10.1. Indonesia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.10.2. Indonesia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.10.3. Indonesia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.10.4. Indonesia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.10.5. Indonesia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.11. AI In Pathology Market – South Korea
10.5.11.1. South Korea: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.11.2. South Korea: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.11.3. South Korea: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.11.4. South Korea: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.11.5. South Korea: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.12. AI In Pathology Market – Australia
10.5.12.1. Australia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.12.2. Australia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.12.3. Australia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.12.4. Australia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.12.5. Australia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.5.13. AI In Pathology Market – Rest of Asia Pacific
10.5.13.1. Rest of Asia Pacific: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.5.13.2. Rest of Asia Pacific: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.5.13.3. Rest of Asia Pacific: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.5.13.4. Rest of Asia Pacific: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.5.13.5. Rest of Asia Pacific: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.6. AI In Pathology Market – Middle East & Africa
10.6.1. Middle East & Africa: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.6.2. Middle East & Africa: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.6.3. Middle East & Africa: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.6.4. Middle East & Africa: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.6.5. Middle East & Africa: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.6.6. AI In Pathology Market – Saudi Arabia
10.6.6.1. Saudi Arabia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.6.6.2. Saudi Arabia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.6.6.3. Saudi Arabia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.6.6.4. Saudi Arabia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.6.6.5. Saudi Arabia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.6.7. AI In Pathology Market – UAE
10.6.7.1. UAE: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.6.7.2. UAE: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.6.7.3. UAE: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.6.7.4. UAE: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.6.7.5. UAE: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.6.8. AI In Pathology Market – Israel
10.6.8.1. Israel: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.6.8.2. Israel: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.6.8.3. Israel: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.6.8.4. Israel: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.6.8.5. Israel: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.6.9. AI In Pathology Market – South Africa
10.6.9.1. South Africa: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.6.9.2. South Africa: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.6.9.3. South Africa: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.6.9.4. South Africa: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.6.9.5. South Africa: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.6.10. AI In Pathology Market – Rest of Middle East & Africa
10.6.10.1. Rest of Middle East & Africa: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.6.10.2. Rest of Middle East & Africa: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.6.10.3. Rest of Middle East & Africa: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.6.10.4. Rest of Middle East & Africa: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.6.10.5. Rest of Middle East & Africa: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.7. AI In Pathology Market – Latin America
10.7.1. Latin America: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.7.2. Latin America: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.7.3. Latin America: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.7.4. Latin America: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.7.5. Latin America: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.7.6. AI In Pathology Market – Mexico
10.7.6.1. Mexico: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.7.6.2. Mexico: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.7.6.3. Mexico: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.7.6.4. Mexico: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.7.6.5. Mexico: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.7.7. AI In Pathology Market – Brazil
10.7.7.1. Brazil: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.7.7.2. Brazil: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.7.7.3. Brazil: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.7.7.4. Brazil: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.7.7.5. Brazil: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.7.8. AI In Pathology Market – Argentina
10.7.8.1. Argentina: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.7.8.2. Argentina: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.7.8.3. Argentina: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.7.8.4. Argentina: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.7.8.5. Argentina: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
10.7.9. AI In Pathology Market – Rest of Latin America
10.7.9.1. Rest of Latin America: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
10.7.9.2. Rest of Latin America: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
10.7.9.3. Rest of Latin America: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
10.7.9.4. Rest of Latin America: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
10.7.9.5. Rest of Latin America: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
11. Competitive Landscape
11.1. Expansion and Acquisition Analysis
11.1.1. Expansion
11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
12.1. Aiforia Technologies Plc
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Recent Development
12.2. Akoya Biosciences, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Benchmarking
12.2.4. Recent Development
12.3. Deep Bio Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Benchmarking
12.3.4. Recent Development
12.4. Hologic, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Benchmarking
12.4.4. Recent Development
12.5. Ibex Medical Analytics Ltd.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Benchmarking
12.5.4. Recent Development
12.6. Indica Labs Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Benchmarking
12.6.4. Recent Development
12.7. Koninklijke Philips N.V.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Benchmarking
12.7.4. Recent Development
12.8. Mindpeak GmbH
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Benchmarking
12.8.4. Recent Development
12.9. OptraScan, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Benchmarking
12.9.4. Recent Development
12.10. Paige AI, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Benchmarking
12.10.4. Recent Development
12.11. Proscia Inc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Benchmarking
12.11.4. Recent Development
12.12. Techcyte, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Benchmarking
12.12.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.